Chinese researchers use AI to spur glaucoma pipeline

A team of Chinese researchers has identified a promising candidate for glaucoma treatment using artificial intelligence tools. 

Researchers from Macau University and Guangzhou National Laboratory used AI-driven models to identify molecules that could inhibit receptor-interacting protein kinase 3 (RIPK3), a key player in the pathology of the progressive eye disorder. 

The research led to the identification of HG9-91-01, a molecule which has demonstrated potential in laboratory models to protect retinal cells and prevent optic nerve damage.